ScholarIQanswers from OpenAlex
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
PaperCitations, authors & open-access status
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cytotoxic CD8+ T cells in cancer and cancer immunotherapy have?
ScholarIQcitation count
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy has 1,721 citations in the OpenAlex counts ScholarIQ stores.
When was Cytotoxic CD8+ T cells in cancer and cancer immunotherapy published?
ScholarIQyear
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy has 2020 year in the ScholarIQ index.
What is the open-access status of Cytotoxic CD8+ T cells in cancer and cancer immunotherapy?
ScholarIQoa status
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy has hybrid oa status in the ScholarIQ index.
What is the DOI of Cytotoxic CD8+ T cells in cancer and cancer immunotherapy?
ScholarIQdoi
The DOI for Cytotoxic CD8+ T cells in cancer and cancer immunotherapy is on the source record.
What is the PMID of Cytotoxic CD8+ T cells in cancer and cancer immunotherapy?
ScholarIQpmid
The PMID for Cytotoxic CD8+ T cells in cancer and cancer immunotherapy is on the source record.
What is the OpenAlex record for Cytotoxic CD8+ T cells in cancer and cancer immunotherapy?
ScholarIQopenalex
The OpenAlex for Cytotoxic CD8+ T cells in cancer and cancer immunotherapy is on the source record.